Authors: WEISS SR MCFARLAND BH BURKHART GA HO PTC

Citation: Sr. Weiss et al., CANCER RECURRENCES AND 2ND PRIMARY CANCERS AFTER USE OF ANTIHISTAMINES OR ANTIDEPRESSANTS, Clinical pharmacology and therapeutics, 63(5), 1998, pp. 594-599

Authors: FITZSIMMONS SC BURKHART GA BOROWITZ D GRAND RJ HAMMERSTROM T DURIE PR LLOYDSTILL JD LOWENFELS AB

Citation: Sc. Fitzsimmons et al., HIGH-DOSE PANCREATIC-ENZYME SUPPLEMENTS AND FIBROSING COLONOPATHY IN CHILDREN WITH CYSTIC-FIBROSIS, The New England journal of medicine, 336(18), 1997, pp. 1283-1289

Authors: BURKHART GA

Citation: Ga. Burkhart, RACE AND ANGIOEDEMA, Clinical pharmacology and therapeutics, 61(6), 1997, pp. 700-700

Authors: BURKHART GA SEVKA MJ TEMPLE R HONIG PK

Citation: Ga. Burkhart et al., TEMPORAL DECLINE IN FILLING PRESCRIPTIONS FOR TERFENADINE CLOSELY IN TIME WITH THOSE FOR EITHER KETOCONAZOLE OR ERYTHROMYCIN, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 93-96

Authors: BURKHART GA

Citation: Ga. Burkhart, ASPIRIN AND COLORECTAL-CANCER, Annals of internal medicine, 123(5), 1995, pp. 390-391

Authors: BURKHART GA FREIMAN J

Citation: Ga. Burkhart et J. Freiman, THE RISK OF LIFE-THREATENING CARDIOVASCULAR EVENTS WITH TERFENADINE, The American journal of cardiology, 75(2), 1995, pp. 213-214